Scarica l'app Stockscreener
20.26
0.95%
0.19
Dopo l'orario di chiusura:
20.25
-0.01
-0.05%
Precedente Chiudi:
$20.07
Aprire:
$20.73
Volume 24 ore:
100.77K
Relative Volume:
0.70
Capitalizzazione di mercato:
$190.26M
Reddito:
-
Utile/perdita netta:
$-81.17M
Rapporto P/E:
-1.9991
EPS:
-10.1344
Flusso di cassa netto:
$-82.84M
1 W Prestazione:
+5.85%
1M Prestazione:
+26.55%
6M Prestazione:
-20.92%
1 anno Prestazione:
-58.65%
Intervallo 1D:
$19.60
$20.73
Intervallo di 1 settimana:
$18.52
$21.62
Portata 52W:
$10.29
$98.00
Korro Bio Inc Stock (KRRO) Company Profile
Nome
Korro Bio Inc
Settore
Industria
Telefono
617-468-1999
Indirizzo
60 FIRST STREET, CAMBRIDGE
Confronta KRRO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
20.26 | 185.18M | 0 | -81.17M | -82.84M | -10.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.18 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
587.65 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.20 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
708.09 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.91 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-04-16 | Iniziato | Chardan Capital Markets | Buy |
| 2025-01-10 | Iniziato | Oppenheimer | Outperform |
| 2024-10-21 | Iniziato | Raymond James | Strong Buy |
| 2024-08-14 | Iniziato | William Blair | Outperform |
| 2024-03-28 | Reiterato | H.C. Wainwright | Buy |
| 2024-02-27 | Iniziato | BMO Capital Markets | Outperform |
| 2023-12-04 | Iniziato | H.C. Wainwright | Buy |
| 2023-11-29 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-11-10 | Iniziato | Piper Sandler | Overweight |
| 2023-02-15 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | Downgrade | Cowen | Outperform → Market Perform |
| 2021-09-22 | Downgrade | Goldman | Buy → Neutral |
| 2021-01-27 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-12-22 | Iniziato | B. Riley Securities | Buy |
| 2020-07-14 | Iniziato | Oppenheimer | Outperform |
| 2020-05-18 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-10-28 | Iniziato | Cowen | Outperform |
| 2019-10-28 | Iniziato | Goldman | Buy |
| 2019-10-28 | Iniziato | JP Morgan | Overweight |
Mostra tutto
Korro Bio Inc Borsa (KRRO) Ultime notizie
Can Korro Bio Inc. Escape Recent Bear ChannelWatch List & AI Enhanced Trading Signals - newsyoung.net
Understanding Korro Bio Inc.’s price movementWeekly Profit Recap & Weekly Breakout Watchlists - Newser
Real time social sentiment graph for Korro Bio Inc.Market Activity Recap & Daily Volume Surge Signals - Newser
Published on: 2025-08-20 05:17:51 - Newser
Institutional scanner results for Korro Bio Inc.2025 Volume Leaders & Real-Time Volume Analysis - Newser
Can a trend reversal in Korro Bio Inc. lead to recoveryMarket Risk Report & Safe Entry Momentum Tips - Newser
Order flow analysis tools used on Korro Bio Inc.Weekly Earnings Recap & Real-Time Volume Trigger Notifications - Newser
Korro Bio Inc. stock trend outlook and recovery pathMarket Risk Summary & Safe Swing Trade Setup Alerts - Newser
Will Korro Bio Inc. see short term momentum2025 Technical Overview & Fast Entry High Yield Stock Tips - Newser
Building trade automation scripts for Korro Bio Inc.Risk Management & Daily Profit Focused Screening - Newser
Applying big data sentiment scoring on Korro Bio Inc.Buy Signal & Fast Gain Swing Alerts - Newser
Will Korro Bio Inc. bounce back from current supportAnalyst Upgrade & Safe Investment Capital Preservation Plans - Newser
Will Breakout in Korro Bio Inc. Sustain Through Next Week - mustnews.co.kr
Will Korro Bio Inc. continue its uptrend2025 Market Sentiment & Consistent Growth Equity Picks - Newser
Published on: 2025-08-19 15:08:52 - Newser
What institutions are buying Korro Bio Inc. stock nowRate Hike & Technical Confirmation Trade Alerts - Newser
Ranking Korro Bio Inc. among high performing stocks via toolsPortfolio Value Summary & AI Forecasted Entry and Exit Points - Newser
Is now a turning point for Korro Bio Inc.Portfolio Update Report & Daily Profit Focused Stock Screening - Newser
Published on: 2025-08-19 04:45:12 - Newser
Technical analysis overview for Korro Bio Inc. stockJuly 2025 Price Swings & Accurate Buy Signal Alerts - Newser
How Korro Bio Inc. stock performs during market volatilityQuarterly Trade Review & AI Enhanced Trading Signals - beatles.ru
FY2025 EPS Estimates for Korro Bio Reduced by Analyst - Defense World
How Resilient Is Korro Bio Inc. Stock During Economic Downturns2025 Analyst Calls & Weekly High Return Forecasts - Newser
Tick level data insight on Korro Bio Inc. volatility2025 Winners & Losers & Weekly Return Optimization Alerts - Newser
Using AI based signals to follow Korro Bio Inc.Weekly Trade Report & AI Powered Buy/Sell Recommendations - Newser
FY2025 EPS Estimates for Korro Bio Cut by Cantor Fitzgerald - Defense World
Korro Bio, Inc. (NASDAQ:KRRO) Receives Average Rating of “Buy” from Analysts - Defense World
How moving averages guide Korro Bio Inc. tradingTrade Performance Summary & Verified Momentum Stock Alerts - Newser
Korro Bio Inc. stock outlook for YEARWeekly Market Summary & Free Safe Entry Trade Signal Reports - Newser
Will earnings trigger a reversal in Korro Bio Inc.Wall Street Watch & Weekly Consistent Profit Watchlists - Newser
Q3 Earnings Forecast for Korro Bio Issued By HC Wainwright - Defense World
Korro Bio Inc Azioni (KRRO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Korro Bio Inc Azioni (KRRO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Agarwal Vineet | Chief Financial Officer |
Nov 11 '24 |
Sale |
70.00 |
800 |
56,000 |
0 |
0.95%
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):